Stakeholders Hope Bill Will Create IRA Drug Negotiation Parity Between Biologics and Small Molecules

Congressional legislation seeks to “equalize” the negotiating period between biologics and small molecules under the Inflation Reduction Act’s Drug Price Negotiation Program.